<
AI
Automation
Science
Innovation
Open Source
Blockchain
Social Media
Startups
Culture
Cloud
>

qz
Karyopharm Therapeutics (KPTI) Stock Jumps 6.9%: Will It Continue to Soar?

Karyopharm Therapeutics (KPTI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for [...]

Discover Copy
Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

thenextweb
Cambridge biotech STORM Therapeutics raises $56M

STC-15 is the world’s first RNA-modifying enzyme inhibitor to reach human trials. Phase 1 showed durable tumour regression across multiple sarcoma subtypes. The $56M Series C is backed entirely by e [...]

Match Score: 51.17

Destination
Viking Therapeutics closer to bringing its Ozempic competitor to market

Viking Therapeutics (VKTX), the developer of a promising experimental weight-loss drug, has announced a multi-year partnership with CordenPharma, a leading contract manufacturing firm.Read more... [...]

Match Score: 40.94

qz
CoreWeave (CRWV) Stock Jumps 10.9%: Will It Continue to Soar?

CoreWeave (CRWV) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock co [...]

Match Score: 37.62

qz
SBA Communications (SBAC) Stock Jumps 18.9%: Will It Continue to Soar?

SBA Communications (SBAC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in FFO estimate revisions cou [...]

Match Score: 35.70

qz
Is C4 Therapeutics (CCCC) Stock Outpacing Its Medical Peers This Year?

Here is how C4 Therapeutics, Inc. (CCCC) and Align Technology (ALGN) have performed compared to their sector so far this year. [...]

Match Score: 34.55

qz
Viridian Therapeutics (VRDN) Soars 5.6%: Is Further Upside Left in the Stock?

Viridian Therapeutics (VRDN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help [...]

Match Score: 34.55

qz
Relay Therapeutics (RLAY) Surges 16.4%: Is This an Indication of Further Gains?

Relay Therapeutics (RLAY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the sto [...]

Match Score: 30.70

qz
After Plunging 30.8% in 4 Weeks, Here's Why the Trend Might Reverse for Maze Therapeutics, Inc. (MAZE)

The heavy selling pressure might have exhausted for Maze Therapeutics, Inc. (MAZE) as it is technically in oversold territory now. In addition to this technical [...]

Match Score: 30.70

Destination
Nanoscope Therapeutics CEO Sulagna Bhattacharya on tackling rare eye diseases

Nanoscope Therapeutics CEO Sulagna Bhattacharya discusses how the company is tackling rare eye diseases [...]

Match Score: 30.70